TRIM33 and cancer: The higher levels of plasma VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ were depicted in the Untreated Cancer TIF1-γ-DM group than in the Non-cancer TIF1-γ-DM group (Figure 3).